Our recognition
Latest stories
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results 22 February 2024
- Hikma – A legacy of quality for a better future Insight, Corporate 24 June 2024 Hikma – A legacy of quality for a better future
- Hikma acquires Xellia’s differentiated portfolio and enhances Injectables pipeline, manufacturing capabilities and R&D Press Release, Corporate 17 June 2024 Hikma acquires Xellia’s differentiated portfolio and enhances Injectables pipeline, manufacturing capabilities and R&D
- Hikma Pharmaceuticals reaffirms commitment to expanding access to overdose-reversal medicine naloxone at White House meeting Press Release, Corporate 06 June 2024 Hikma Pharmaceuticals reaffirms commitment to expanding access to overdose-reversal medicine naloxone at White House meeting
- Hikma opens new UK office to support NHS supply, strengthening European presence Press Release, Corporate 03 June 2024 Hikma opens new UK office to support NHS supply, strengthening European presence
Related content